A groundbreaking study has revealed that artificial intelligence technology can detect elevated heart disease risk in women during routine mammogram screenings, offering a potentially life-saving dual benefit from a single medical appointment.
The research, published in the European Heart Journal, analyzed mammography data from 123,762 women who participated in breast cancer screening programs but had no known cardiovascular disease at the time of their scans. The AI system examined calcium deposits in breast arteries visible on standard X-ray mammography images, using these deposits as indicators of cardiovascular risk.
Dr. Hari Trivedi from Emory University, who led the study, emphasized the critical importance of this development for women's health. He noted that heart disease remains the leading cause of death in women worldwide, yet women consistently receive less diagnosis and treatment compared to men. The innovation allows for cardiovascular risk assessment without requiring additional appointments, procedures, or expenses.
The findings demonstrated a clear correlation between arterial calcification levels and cardiovascular disease risk. Women with mild calcification showed approximately 30 percent higher likelihood of experiencing serious cardiovascular events compared to those with no calcification. Those with moderate calcification faced a 70 percent increased risk, while women with severe calcification experienced risk levels two to three times higher than their counterparts without arterial deposits.
Particularly significant was the discovery that these risk patterns held true even among younger women under 50 years of age, a demographic traditionally considered low-risk for cardiovascular disease. The correlation remained statistically significant after researchers accounted for other known risk factors including diabetes and smoking habits.
The study represents the largest investigation of its kind and included diverse ethnic populations across the United States health system, strengthening the applicability of its findings to broad patient populations. Dr. Trivedi explained that arterial calcification, also known as hardening of the arteries, serves as an established indicator of elevated risk for heart attacks, strokes, heart failure, and mortality.
For patients, this advancement means that routine mammograms could provide dual health intelligence, screening simultaneously for breast cancer and cardiovascular disease risk. Such information could prompt timely conversations with physicians about preventive measures, including cholesterol testing or medication interventions that might otherwise be delayed or overlooked.
For healthcare providers, the technology offers a practical mechanism to identify women at cardiovascular risk who might otherwise remain undetected until symptoms emerge. The research team is now planning clinical trials to establish protocols for integrating the AI tool into existing imaging workflows and developing clear guidelines for patient and physician notification.
Professor Lori Daniels from the University of California San Diego, who was not involved in the research, provided commentary supporting the findings. She highlighted that approximately two-thirds of women aged 50 to 69 in the European Union and nearly 70 percent of American women aged 45 and older comply with mammography screening guidelines, yet most remain unaware of their cardiovascular disease risk.
Professor Daniels argued that breast arterial calcification assessment has the potential to address this knowledge gap by leveraging an established cancer-screening platform that women already trust and regularly access. She emphasized that the time has arrived to transition this capability from observation to implementation, advancing prevention efforts for what remains the primary cause of death among women.
The development represents a significant advancement in addressing the historical underdiagnosis and undertreatment of cardiovascular disease in women. By extracting additional diagnostic value from existing screening procedures, the technology could transform preventive care without imposing additional burdens on patients or healthcare systems.